Imaging data in this collection is produced through the VA RePOP activity in conjunction with the The Applied Proteogenomics OrganizationaL Learning and Outcomes (APOLLO) program. The Research for Pre
Sensitivity profile of BOLD-100 and cisplatin across a 319 cancer cell line panel. IC50, AUC, GRmax, GR50 provided for both cisplatin and BOLD-100. Tissue type, subtype and cell culture media for eac
Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) studyEGA dataset EGAD00001004928